# Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors

> **NCT03525080** · NA · COMPLETED · sponsor: **Center Eugene Marquis** · enrollment: 16 (actual)

## Conditions studied

- Brain Neoplasms
- Adult Brain Tumor

## Interventions

- **DIAGNOSTIC_TEST:** PET imagery

## Key facts

- **NCT ID:** NCT03525080
- **Lead sponsor:** Center Eugene Marquis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-12
- **Primary completion:** 2019-09-11
- **Final completion:** 2019-09-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03525080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03525080, "Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03525080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*